Literature DB >> 11748060

Force-velocity relationship of myogenically active arterioles.

Michael J Davis1, Judy Davidson.   

Abstract

We compared the shortening velocity of smooth muscle in arterioles that had low or high levels of myogenic tone or norepinephrine (NE)-induced tone. We hypothesized that enhanced myogenic tone of arterioles reflects an enhanced maximum velocity of shortening of arteriolar smooth muscle in a way that is different from that produced by NE. These concepts are untested assumptions of arteriolar mechanics. Second-order arterioles from hamster cheek pouch (passive diameter at 40 mmHg = 42 microm) were isolated and cannulated for in vitro study. In the absence of flow, pressure was controlled by hydraulic pumps so that servo control of wall tension could be achieved from measurement of internal diameter and pressure. Isotonic quick-release protocols were used to measure the initial velocity of shortening following release from control wall tension (afterload) to a series of fractional afterloads. After release, the initial rates of shortening were fit to the Hill equation to obtain coefficients for a hyperbolic fit of the velocity-afterload relationship. The maximal unloaded shortening velocity for partially activated arterioles (V'(max)) was determined from the y-intercept of each plot. Using this procedure, we compared V'(max) from two groups of arterioles equilibrated at low or high pressure, i.e., with low or high myogenic tone. Arterioles with higher myogenic tone had higher values of V'(max) than arterioles with lower myogenic tone. V'(max) for arterioles partially activated with NE at low pressure was comparable to V'(max) for arterioles with high myogenic tone, but NE produced high velocities at low force, whereas enhanced myogenic tone produced roughly parallel shifts in velocity and force. The results suggest that increased myogenic tone does indeed reflect enhanced activation of arteriolar smooth muscle, and this effect is mechanically different from that produced by NE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11748060     DOI: 10.1152/ajpheart.2002.282.1.H165

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Myogenic constriction and dilation of isolated lymphatic vessels.

Authors:  Michael J Davis; Ann M Davis; Christine W Ku; Anatoliy A Gashev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-21       Impact factor: 4.733

2.  Myogenic origin of the hypotension induced by rapid changes in posture in awake dogs following autonomic blockade.

Authors:  Brett J Wong; Don D Sheriff
Journal:  J Appl Physiol (1985)       Date:  2008-10-16

3.  Intrinsic increase in lymphangion muscle contractility in response to elevated afterload.

Authors:  Michael J Davis; Joshua P Scallan; John H Wolpers; Mariappan Muthuchamy; Anatoliy A Gashev; David C Zawieja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-10       Impact factor: 4.733

4.  Vasoresponsiveness of collateral vessels in the rat hindlimb: influence of training.

Authors:  Patrick N Colleran; Zeyi Li; Hsiao T Yang; M Harold Laughlin; Ronald L Terjung
Journal:  J Physiol       Date:  2010-03-01       Impact factor: 5.182

5.  Influence of layer separation on the determination of stomach smooth muscle properties.

Authors:  Mischa Borsdorf; Markus Böl; Tobias Siebert
Journal:  Pflugers Arch       Date:  2021-04-26       Impact factor: 3.657

6.  Demonstration and Analysis of the Suction Effect for Pumping Lymph from Tissue Beds at Subatmospheric Pressure.

Authors:  Samira Jamalian; Mohammad Jafarnejad; Scott D Zawieja; Christopher D Bertram; Anatoliy A Gashev; David C Zawieja; Michael J Davis; James E Moore
Journal:  Sci Rep       Date:  2017-09-21       Impact factor: 4.379

7.  Signaling and metabolic properties of fast and slow smooth muscle types from mice.

Authors:  Lena Boberg; Ferenc L M Szekeres; Anders Arner
Journal:  Pflugers Arch       Date:  2018-01-29       Impact factor: 3.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.